PRE 14A XBRL

FORM PRE 14A

Company: Outlook Therapeutics, Inc.
Filed: January 31, 2025
Period of Report: January 31, 2025
Accession Number: 0001104659-25-008169

View Document ↗ View on SEC.gov ↗